Twelve-lead electrocardiography usually confirms the presence of a sinus tachycardia and might identify a cardiac underlying cause. Electrocardiography can show atrial flutter, atrial tachycardia ...

Nearly 14 million Americans live with arrhythmias. Learn to identify the warning signs of these common heart rhythm disorders ...

The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...

The trial, Advantage-AF, met its primary endpoints, with 73.4% of patients showing freedom from afib, flutter and atrial tachycardia. Additionally, 81% showed no afib recurrence—including no ...

Several ASX-listed medtech companies are delivering technologies that enhance clinical precision, safety, and efficiency in healthcare.

An electrocardiograph with continuous telemetry showed new-onset paroxysmal atrial flutter without ST-segment ... acutely hypotensive and developed tachycardia. She was transferred to the medical ...

defined as 12-month freedom from a documented 30-second episode of Afib/atrial flutter/atrial tachycardia, failure of pulmonary vein isolation (PVI), cardioversion, antiarrhythmic drug use ...

Most patients undergoing treatment for cavotricuspid isthmus-dependent atrial flutter, atrioventricular nodal reentrant tachycardia, accessory pathways, and focal atrial tachycardias are likely ...

It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low ...

Findings from the trial met all pre-specified safety and effectiveness endpoints and demonstrated: 73.4% freedom from AF, AFL and atrial tachycardia ... typical atrial flutter, which is not ...

Of the remaining 93 episodes the final diagnosis was PSVT in 58 (63%), atrial fibrillation in 22 (24%), atrial flutter in 7 (7%), ventricular tachycardia in 2 (2%), and sinus tachycardia in 4 (4%) ...

The study found 73.4% of patients were free from AFib, atrial flutter and atrial tachycardia, exceeding the goal of 40% or higher. The safety event rate of 2.4% met the goal of 12% or lower. In ...